董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Irene Chang Britt | 女 | Director | 54 | 19.54万美元 | 未持股 | 2017-02-28 |
| Apurva S. Mody | 男 | Chief Executive Officer and Director | 50 | 380.17万美元 | 未持股 | 2017-02-28 |
| James R. Craigie | 男 | Director | 63 | 13.44万美元 | 未持股 | 2017-02-28 |
| Gary M. Pfeiffer | 男 | Director | 67 | 12.94万美元 | 未持股 | 2017-02-28 |
| Jonathan S. Wolfson | 男 | Director | 46 | 179.73万美元 | 未持股 | 2017-02-28 |
| Michael V. Arbige | 男 | Director | 62 | 12.44万美元 | 未持股 | 2017-02-28 |
| Jerry Fiddler | 男 | Director | 65 | 16.43万美元 | 未持股 | 2017-02-28 |
| Ian T. Clark | 男 | Director | 56 | 13.44万美元 | 未持股 | 2017-02-28 |
| Irene Chang Britt | 女 | Director | 54 | 未披露 | 未持股 | 2017-02-28 |
| James R. Craigie | 男 | Director | 63 | 未披露 | 未持股 | 2017-02-28 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Apurva S. Mody | 男 | Chief Executive Officer and Director | 50 | 380.17万美元 | 未持股 | 2017-02-28 |
| Tyler W. Painter | 男 | Chief Financial Officer & Chief Operating Officer | 45 | 98.76万美元 | 未持股 | 2017-02-28 |
| Peter J. Licari | 男 | Chief Technology Officer | 53 | 89.79万美元 | 未持股 | 2017-02-28 |
| Paul T. Quinlan | 男 | Chief Legal Officer, General Counsel & Corporate Secretary | 54 | 98.17万美元 | 未持股 | 2017-02-28 |
董事简历
中英对照 | 中文 | 英文- Irene Chang Britt
-
Irene Chang Britt于2005年加入Campbell Soup Company，担任多个职位，包括Pepperidge Farm，Inc.的总裁和高级副总裁兼首席战略官，负责全球战略发展，全球营销服务和全球消费者洞察。 在加入Campbell之前，她在Kraft Foods 和Kimberly-Clark担任领导职务。 Britt女士目前在TerraVia Inc. 和Dunkin Brands Group, Inc.的董事会任职，包括Dunkin Brands的审计委员会，之前于2011年11月至2012年10月在Sunoco, Inc. 董事会任职。
Irene Chang Britt is a former Fortune 500 C-Suite executive, having spent 30 years working for companies such as Kimberly-Clark, Kraft Foods and Campbell Soup Co, in progressively higher leadership roles. Her more recent roles at Campbell were President, Pepperidge Farm, SVP Global Baking and Snacking, Global Chief Strategy Officer and President, North America Foodservice. Prior to Campbell, Ms. Britt held leadership roles with Kraft Foods and Kimberly-Clark. Ms. Britt currently serves on the boards of Dunkin Brands Group, Inc., including as chair of their nominating and corporate governance committee and as a member of their audit committee, and Brighthouse Financial, Inc., including as chair of their nominating and corporate governance committee and as a member of their compensation and investment committees. She is also a director of Baybridge Seniors Housing Inc., a privately-held health care company, and Peloton Capital Management, a small/mid-cap private capital fund. She was a director of TerraVia Holdings Inc. from March 2017 to January 2018 where she served as chairperson of the board and as member of their compensation committee. - Irene Chang Britt于2005年加入Campbell Soup Company，担任多个职位，包括Pepperidge Farm，Inc.的总裁和高级副总裁兼首席战略官，负责全球战略发展，全球营销服务和全球消费者洞察。 在加入Campbell之前，她在Kraft Foods 和Kimberly-Clark担任领导职务。 Britt女士目前在TerraVia Inc. 和Dunkin Brands Group, Inc.的董事会任职，包括Dunkin Brands的审计委员会，之前于2011年11月至2012年10月在Sunoco, Inc. 董事会任职。
- Irene Chang Britt is a former Fortune 500 C-Suite executive, having spent 30 years working for companies such as Kimberly-Clark, Kraft Foods and Campbell Soup Co, in progressively higher leadership roles. Her more recent roles at Campbell were President, Pepperidge Farm, SVP Global Baking and Snacking, Global Chief Strategy Officer and President, North America Foodservice. Prior to Campbell, Ms. Britt held leadership roles with Kraft Foods and Kimberly-Clark. Ms. Britt currently serves on the boards of Dunkin Brands Group, Inc., including as chair of their nominating and corporate governance committee and as a member of their audit committee, and Brighthouse Financial, Inc., including as chair of their nominating and corporate governance committee and as a member of their compensation and investment committees. She is also a director of Baybridge Seniors Housing Inc., a privately-held health care company, and Peloton Capital Management, a small/mid-cap private capital fund. She was a director of TerraVia Holdings Inc. from March 2017 to January 2018 where she served as chairperson of the board and as member of their compensation committee.
- Apurva S. Mody
-
ApurvaS.Mody自2016年以来一直担任我们的首席执行官兼董事会成员。在加入我们之前，他曾于2010年至2015年担任Mars，Inc.的Mars Food America总裁。从2008年到2010年，他担任消费品创新公司The Brand Accelerator的首席执行官，从2002年到2008年，他曾担任Del Monte Foods公司（食品公司）的多种职务，最近担任消费品部门的高级副总裁兼董事总经理。从1995年到2000年，Mody先生在宝洁公司（Proctor and Gamble Company）担任多个职位，该公司是一家包装消费品公司，最近担任全球新产品开发的高级品牌经理。Mody先生拥有密歇根大学（University of Michigan）的本科学位和密歇根大学（University of Michigan）的工商管理硕士学位。
Apurva S. Mody has been our Chief Executive Officer and member of our board of directors since 2016. Prior to joining us, he was President, Mars Food America, at Mars, Inc. from 2010 to 2015. From 2008 to 2010 he was Chief Executive Officer of The Brand Accelerator, a consumer goods innovation company, and from 2002 to 2008 he held various positions within Del Monte Foods, a food company, most recently as Senior Vice President and Managing Director, Consumer Products Division. From 1995 to 2000 Mr. Mody held various positions with The Proctor and Gamble Company, a consumer packaged goods company, most recently Senior Brand Manager, Global New Product Development. Mr. Mody holds an undergraduate degree from the University of Michigan and an M.B.A. with Distinction from the University of Michigan. - ApurvaS.Mody自2016年以来一直担任我们的首席执行官兼董事会成员。在加入我们之前，他曾于2010年至2015年担任Mars，Inc.的Mars Food America总裁。从2008年到2010年，他担任消费品创新公司The Brand Accelerator的首席执行官，从2002年到2008年，他曾担任Del Monte Foods公司（食品公司）的多种职务，最近担任消费品部门的高级副总裁兼董事总经理。从1995年到2000年，Mody先生在宝洁公司（Proctor and Gamble Company）担任多个职位，该公司是一家包装消费品公司，最近担任全球新产品开发的高级品牌经理。Mody先生拥有密歇根大学（University of Michigan）的本科学位和密歇根大学（University of Michigan）的工商管理硕士学位。
- Apurva S. Mody has been our Chief Executive Officer and member of our board of directors since 2016. Prior to joining us, he was President, Mars Food America, at Mars, Inc. from 2010 to 2015. From 2008 to 2010 he was Chief Executive Officer of The Brand Accelerator, a consumer goods innovation company, and from 2002 to 2008 he held various positions within Del Monte Foods, a food company, most recently as Senior Vice President and Managing Director, Consumer Products Division. From 1995 to 2000 Mr. Mody held various positions with The Proctor and Gamble Company, a consumer packaged goods company, most recently Senior Brand Manager, Global New Product Development. Mr. Mody holds an undergraduate degree from the University of Michigan and an M.B.A. with Distinction from the University of Michigan.
- James R. Craigie
-
James R. Craigie于2016年至2019年5月担任Church&Dwight Co.，Inc.“Church&Dwight”，一家家用产品制造公司的非执行主席。Craigie先生曾在Church&Dwight担任多个高级职务，包括2007年至2016年的董事长和首席执行官，以及2004年至2007年的总裁和首席执行官。他自2004年起担任Church&Dwight董事会成员。从1998年到2003年，Craigie先生担任Spalding Sports Worldwide的总裁兼首席执行官和董事会成员，Spalding Sports Worldwide是一家体育用品公司，其继任者Top Flite Golf Co是一家专注于高尔夫设备的体育用品公司。从1983年到1998年，克雷吉先生在卡夫食品公司担任过各种高级管理职位。在进入私营行业之前，他曾在美国海军担任六年军官。Craigie先生目前担任Church&Dwight和一家休闲餐饮公司Bloomin'Brands，Inc.的董事会成员，并担任非执行主席。他还担任儿童基金会纽约区域理事会成员。克雷吉目前还担任私人股本公司Cove Hill Partners的投资者和顾问委员会成员。Craigie先生曾是Meredith Corporation、TerraVia Holdings Inc.的董事会成员，之前称为Solazyme，Inc.、World Kitchens LLC和Nielsen Media Research，Inc。Craigie先生拥有罗切斯特大学的本科学位和哈佛大学的工商管理硕士学位。
James R. Craigie,May 2019 - Present: Retired Chief Executive Officer and Director of Church & Dwight Co., Inc. “Church & Dwight”, a household products manufacturing company.2016 - May 2019: Retired Chief Executive Officer and Non-Executive Chairman of Church & Dwight.2007 - 2016: Chairman and Chief Executive Officer of Church & Dwight. 2004 - 2007: President and Chief Executive Officer of Church & Dwight.1998 - 2003: President and Chief Executive Officer and a member of the board of directors of Spalding Sports Worldwide, and its successor, Top-Flite Golf Co..Prior to 1998: Various senior management positions with Kraft Foods, Inc., and six -6 years' service as an officer in the U.S. Navy.Church & Dwight, Bloomin' Brands, Inc..Meredith Corporation, TerraVia Holdings Inc. (previously called Solazyme, Inc.), World Kitchens LLC, and Nielsen Media Research, Inc.. - James R. Craigie于2016年至2019年5月担任Church&Dwight Co.，Inc.“Church&Dwight”，一家家用产品制造公司的非执行主席。Craigie先生曾在Church&Dwight担任多个高级职务，包括2007年至2016年的董事长和首席执行官，以及2004年至2007年的总裁和首席执行官。他自2004年起担任Church&Dwight董事会成员。从1998年到2003年，Craigie先生担任Spalding Sports Worldwide的总裁兼首席执行官和董事会成员，Spalding Sports Worldwide是一家体育用品公司，其继任者Top Flite Golf Co是一家专注于高尔夫设备的体育用品公司。从1983年到1998年，克雷吉先生在卡夫食品公司担任过各种高级管理职位。在进入私营行业之前，他曾在美国海军担任六年军官。Craigie先生目前担任Church&Dwight和一家休闲餐饮公司Bloomin'Brands，Inc.的董事会成员，并担任非执行主席。他还担任儿童基金会纽约区域理事会成员。克雷吉目前还担任私人股本公司Cove Hill Partners的投资者和顾问委员会成员。Craigie先生曾是Meredith Corporation、TerraVia Holdings Inc.的董事会成员，之前称为Solazyme，Inc.、World Kitchens LLC和Nielsen Media Research，Inc。Craigie先生拥有罗切斯特大学的本科学位和哈佛大学的工商管理硕士学位。
- James R. Craigie,May 2019 - Present: Retired Chief Executive Officer and Director of Church & Dwight Co., Inc. “Church & Dwight”, a household products manufacturing company.2016 - May 2019: Retired Chief Executive Officer and Non-Executive Chairman of Church & Dwight.2007 - 2016: Chairman and Chief Executive Officer of Church & Dwight. 2004 - 2007: President and Chief Executive Officer of Church & Dwight.1998 - 2003: President and Chief Executive Officer and a member of the board of directors of Spalding Sports Worldwide, and its successor, Top-Flite Golf Co..Prior to 1998: Various senior management positions with Kraft Foods, Inc., and six -6 years' service as an officer in the U.S. Navy.Church & Dwight, Bloomin' Brands, Inc..Meredith Corporation, TerraVia Holdings Inc. (previously called Solazyme, Inc.), World Kitchens LLC, and Nielsen Media Research, Inc..
- Gary M. Pfeiffer
-
Gary M. Pfeiffer ，他于2006年退任杜邦公司（E.I. DuPont de Nemours & Co.） 的高级副总裁兼首席财务官。他于1974年加入杜邦，并负责杜邦及其子公司的金融和国际业务。从2009年1月至6月，他担任特拉华州的财政部秘书。从2005年到2012年，他担任英特奈普网络服务公司的董事，以及塔尔伯特公司的董事。他是特拉华州健康中心的董事会的非执行主席，以及Green tech Capital Advisors公司的咨询委员会成员。2004年12月以来，他一直担任奎斯特诊断公司（Quest Diagnostics）的董事。
Gary M. Pfeiffer,retired in 2006 as the Senior Vice President and Chief Financial Officer of E.I. du Pont de Nemours and Company. He joined DuPont in 1974, where he held positions of increasing responsibility in finance and international operations, as well as in various DuPont divisions. Mr. Pfeiffer served as Secretary of Finance for the state of Delaware from January through June 2009. Mr. Pfeiffer served as a director of Internap Corporation from 2007 to 2020, TerraVia Holdings, Inc. from 2014 to 2017 and Talbots, Inc. from 2005 to 2012. He served as the non-executive Chair of the Board of Directors of Christiana Care Health System, a regional hospital system located in Delaware, from 2012 to 2016. - Gary M. Pfeiffer ，他于2006年退任杜邦公司（E.I. DuPont de Nemours & Co.） 的高级副总裁兼首席财务官。他于1974年加入杜邦，并负责杜邦及其子公司的金融和国际业务。从2009年1月至6月，他担任特拉华州的财政部秘书。从2005年到2012年，他担任英特奈普网络服务公司的董事，以及塔尔伯特公司的董事。他是特拉华州健康中心的董事会的非执行主席，以及Green tech Capital Advisors公司的咨询委员会成员。2004年12月以来，他一直担任奎斯特诊断公司（Quest Diagnostics）的董事。
- Gary M. Pfeiffer,retired in 2006 as the Senior Vice President and Chief Financial Officer of E.I. du Pont de Nemours and Company. He joined DuPont in 1974, where he held positions of increasing responsibility in finance and international operations, as well as in various DuPont divisions. Mr. Pfeiffer served as Secretary of Finance for the state of Delaware from January through June 2009. Mr. Pfeiffer served as a director of Internap Corporation from 2007 to 2020, TerraVia Holdings, Inc. from 2014 to 2017 and Talbots, Inc. from 2005 to 2012. He served as the non-executive Chair of the Board of Directors of Christiana Care Health System, a regional hospital system located in Delaware, from 2012 to 2016.
- Jonathan S. Wolfson
-
Jonathan S. Wolfson，本公司共同创始人；2003年起，担任总裁、首席运营官，直到2008年成为首席执行官。创办Solazyme之前，他在供应链软件公司7thOnline担任过各种职务，涵盖财务、业务及法律方面，最后的是财务与业务开发副总裁。在这之前，他是财务服务软件公司InvestorTree的共同创始人、首席运营官。他在New York University NYU School of Law获得法律学位，在NYU Stern School of Business获得工商管理硕士学位。自本公司成立之时起，他就担任董事。
Jonathan S. Wolfson is a co-founder and was our President and Chief Operating Officer from 2003 to 2008 and from 2008 to 2016 he served as our Chief Executive Officer. He served as Executive Chairman of our board of directors from March 2016 to March 2017 and now serves as a non-employee director on our board of directors. Prior to founding TerraVia, Mr. Wolfson held a variety of positions in finance, business and law, most recently that of Vice President of Finance and Business Development for 7thOnline, Inc., a supply chain software company. Immediately prior to that, Mr. Wolfson was co-founder and Chief Operating Officer of InvestorTree, Inc., a financial services software company. Mr. Wolfson obtained a law degree from New York University NYU School of Law and an M.B.A. from NYU Stern School of Business. He has served as a member of our board of directors since inception. - Jonathan S. Wolfson，本公司共同创始人；2003年起，担任总裁、首席运营官，直到2008年成为首席执行官。创办Solazyme之前，他在供应链软件公司7thOnline担任过各种职务，涵盖财务、业务及法律方面，最后的是财务与业务开发副总裁。在这之前，他是财务服务软件公司InvestorTree的共同创始人、首席运营官。他在New York University NYU School of Law获得法律学位，在NYU Stern School of Business获得工商管理硕士学位。自本公司成立之时起，他就担任董事。
- Jonathan S. Wolfson is a co-founder and was our President and Chief Operating Officer from 2003 to 2008 and from 2008 to 2016 he served as our Chief Executive Officer. He served as Executive Chairman of our board of directors from March 2016 to March 2017 and now serves as a non-employee director on our board of directors. Prior to founding TerraVia, Mr. Wolfson held a variety of positions in finance, business and law, most recently that of Vice President of Finance and Business Development for 7thOnline, Inc., a supply chain software company. Immediately prior to that, Mr. Wolfson was co-founder and Chief Operating Officer of InvestorTree, Inc., a financial services software company. Mr. Wolfson obtained a law degree from New York University NYU School of Law and an M.B.A. from NYU Stern School of Business. He has served as a member of our board of directors since inception.
- Michael V. Arbige
-
Michael V. Arbige，2005年起担任本公司董事。2011年5月，E.I. du Pont de Nemours and Company 收购Genencor International, Inc.（多元化生物技术公司Danisco US的分部），他被任命为DuPont Industrial Biosciences的研发副总裁。他目前负责DuPont Industrial Biosciences研发工作的管理和推进相关的所有事务。1990-2011，他在Genencor担任过各种职务，最后的是研发执行副总裁，任期2009-2011.1982年，他在University of New Hampshire获得微生物生理学与遗传学博士学位。
Michael V. Arbige has been a member of our board of directors since 2005. In May 2011 E.I. du Pont de Nemours and Company acquired Genencor International, Inc., a division of Danisco US Inc., a diversified biotechnology company, and Dr. Arbige was appointed Vice President, Research and Development of DuPont Industrial Biosciences. From 1990 to 2011 Dr. Arbige held a variety of positions at Genencor, most recently as its Executive Vice President of Research and Development, a position he held from 2009 to 2011. He is responsible for all activities associated with managing and driving the research and development activities for the division. Dr. Arbige obtained his Ph.D. in Microbial Physiology and Genetics in 1982 from the University of New Hampshire. - Michael V. Arbige，2005年起担任本公司董事。2011年5月，E.I. du Pont de Nemours and Company 收购Genencor International, Inc.（多元化生物技术公司Danisco US的分部），他被任命为DuPont Industrial Biosciences的研发副总裁。他目前负责DuPont Industrial Biosciences研发工作的管理和推进相关的所有事务。1990-2011，他在Genencor担任过各种职务，最后的是研发执行副总裁，任期2009-2011.1982年，他在University of New Hampshire获得微生物生理学与遗传学博士学位。
- Michael V. Arbige has been a member of our board of directors since 2005. In May 2011 E.I. du Pont de Nemours and Company acquired Genencor International, Inc., a division of Danisco US Inc., a diversified biotechnology company, and Dr. Arbige was appointed Vice President, Research and Development of DuPont Industrial Biosciences. From 1990 to 2011 Dr. Arbige held a variety of positions at Genencor, most recently as its Executive Vice President of Research and Development, a position he held from 2009 to 2011. He is responsible for all activities associated with managing and driving the research and development activities for the division. Dr. Arbige obtained his Ph.D. in Microbial Physiology and Genetics in 1982 from the University of New Hampshire.
- Jerry Fiddler
-
Jerry Fiddler，2004年起，担任本公司的董事、董事长。他是软件上市公司Wind River Systems的创始人；1981-2009，他多次担任其首席执行官，以及董事长/董事，直到它被半导体公司Intel Corporation收购。他目前是Zygote Ventures, LLC的合伙人/首席执行官、University of California, Berkeley的客座教授。他还是一些私营公司和非营利机构的董事。他在University of Illinois获得硕士学位。
Jerry Fiddler has been a member of our board of directors since 2004. He served as Chairman of our board of directors from 2004 to March 2016 and served as lead independent director from March 2016 to March 2017. From 1981 to 2009 Mr. Fiddler was, at various times, the founder, Chief Executive Officer, Chairman and/or director of Wind River Systems, Inc., a publicly held software company, until it was acquired by Intel Corporation, a semiconductor company. Mr. Fiddler is the principal/CEO of Zygote Ventures, LLC. He serves on a number of private company and non-profit boards. Mr. Fiddler obtained an M.S. from the University of Illinois. - Jerry Fiddler，2004年起，担任本公司的董事、董事长。他是软件上市公司Wind River Systems的创始人；1981-2009，他多次担任其首席执行官，以及董事长/董事，直到它被半导体公司Intel Corporation收购。他目前是Zygote Ventures, LLC的合伙人/首席执行官、University of California, Berkeley的客座教授。他还是一些私营公司和非营利机构的董事。他在University of Illinois获得硕士学位。
- Jerry Fiddler has been a member of our board of directors since 2004. He served as Chairman of our board of directors from 2004 to March 2016 and served as lead independent director from March 2016 to March 2017. From 1981 to 2009 Mr. Fiddler was, at various times, the founder, Chief Executive Officer, Chairman and/or director of Wind River Systems, Inc., a publicly held software company, until it was acquired by Intel Corporation, a semiconductor company. Mr. Fiddler is the principal/CEO of Zygote Ventures, LLC. He serves on a number of private company and non-profit boards. Mr. Fiddler obtained an M.S. from the University of Illinois.
- Ian T. Clark
-
Ian T. Clark，曾担任Corvus Pharmaceuticals， Inc.的成员。自2017年1月起担任董事会成员。Clark先生在生物技术和制药行业拥有超过35年的经验，最近担任Genentech的首席执行官和董事会成员，直到他于2016年12月退休。在他担任首席执行官的7年任期内，Clark先生和他的团队向市场推出了11种新药，用于治疗类风湿性关节炎、特发性肺纤维化和各种类型的癌症。Clark先生被Glassdoor评为最高评级的首席执行官之一，被旧金山商业时报评为湾区最受尊敬的首席执行官，并被Heath Business Woman's Association授予年度荣誉导师。在加入Genentech之前，Clark先生在美国、英国、加拿大、东欧和法国的诺华（Novartis）、赛诺菲（Sanofi）、伊瓦克斯（Ivax）和塞尔（Searle）担任各种职务，责任越来越大。目前，他是几家上市生物制药和生物技术公司的董事会成员：Takeda Pharmaceutical Company Limited、Guardant Health， Inc.、Olema Oncology和Kyverna Therapeutics， Inc.。Clark先生曾任职于Forty - Seven Inc.、Shire Pharmaceuticals, Inc.、Kite Pharma, Inc.、Agios Pharmaceuticals, Inc.和Avrobio， Inc.的董事会。他也是生物技术行业协会的董事会成员，联邦储备第12区经济顾问委员会成员，以及格拉德斯通研究所的BioFulcrum董事会成员。Clark先生在英国Southampton大学获得生物科学学士学位和荣誉科学博士学位。
Ian T. Clark,has served as a member of Corvus Pharmaceuticals, Inc. Board since January 2017. Mr. Clark has more than 35 years of experience in the biotechnology and pharmaceutical industry, most recently serving as CEO and member of the board of directors for Genentech, until his retirement in December 2016. During his seven-year tenure as CEO, Mr. Clark and his team brought eleven new medicines to market for patients fighting rheumatoid arthritis, idiopathic pulmonary fibrosis and various types of cancer. Mr. Clark was among the highest rated CEOs by Glassdoor, recognized as the Bay Area's most admired CEO by the San Francisco Business Times and awarded the Honorable Mentor of the Year by the Heath Business Woman's Association. Prior to joining Genentech, Mr. Clark held various positions of increasing responsibility at Novartis, Sanofi, Ivax and Searle, working in the USA, UK, Canada, Eastern Europe and France. Currently, Mr. Clark is on the board of directors of several public biopharmaceutical and biotechnology companies: Takeda Pharmaceutical Company Limited, Guardant Health, Inc., Olema Oncology and Kyverna Therapeutics, Inc. Mr. Clark previously served on the Boards of Forty Seven Inc., Shire Pharmaceuticals, Inc., Kite Pharma, Inc., Agios Pharmaceuticals, Inc. and Avrobio, Inc. He was also on the Board of Biotechnology Industry Association, on the Economic Advisory Council of the 12th District of the Federal Reserve and on the BioFulcrum Board of the Gladstone Institute. Mr. Clark received his Bachelor of Science in Biological Sciences and an Honorary Doctorate of Science from Southampton University in the United Kingdom. - Ian T. Clark，曾担任Corvus Pharmaceuticals， Inc.的成员。自2017年1月起担任董事会成员。Clark先生在生物技术和制药行业拥有超过35年的经验，最近担任Genentech的首席执行官和董事会成员，直到他于2016年12月退休。在他担任首席执行官的7年任期内，Clark先生和他的团队向市场推出了11种新药，用于治疗类风湿性关节炎、特发性肺纤维化和各种类型的癌症。Clark先生被Glassdoor评为最高评级的首席执行官之一，被旧金山商业时报评为湾区最受尊敬的首席执行官，并被Heath Business Woman's Association授予年度荣誉导师。在加入Genentech之前，Clark先生在美国、英国、加拿大、东欧和法国的诺华（Novartis）、赛诺菲（Sanofi）、伊瓦克斯（Ivax）和塞尔（Searle）担任各种职务，责任越来越大。目前，他是几家上市生物制药和生物技术公司的董事会成员：Takeda Pharmaceutical Company Limited、Guardant Health， Inc.、Olema Oncology和Kyverna Therapeutics， Inc.。Clark先生曾任职于Forty - Seven Inc.、Shire Pharmaceuticals, Inc.、Kite Pharma, Inc.、Agios Pharmaceuticals, Inc.和Avrobio， Inc.的董事会。他也是生物技术行业协会的董事会成员，联邦储备第12区经济顾问委员会成员，以及格拉德斯通研究所的BioFulcrum董事会成员。Clark先生在英国Southampton大学获得生物科学学士学位和荣誉科学博士学位。
- Ian T. Clark,has served as a member of Corvus Pharmaceuticals, Inc. Board since January 2017. Mr. Clark has more than 35 years of experience in the biotechnology and pharmaceutical industry, most recently serving as CEO and member of the board of directors for Genentech, until his retirement in December 2016. During his seven-year tenure as CEO, Mr. Clark and his team brought eleven new medicines to market for patients fighting rheumatoid arthritis, idiopathic pulmonary fibrosis and various types of cancer. Mr. Clark was among the highest rated CEOs by Glassdoor, recognized as the Bay Area's most admired CEO by the San Francisco Business Times and awarded the Honorable Mentor of the Year by the Heath Business Woman's Association. Prior to joining Genentech, Mr. Clark held various positions of increasing responsibility at Novartis, Sanofi, Ivax and Searle, working in the USA, UK, Canada, Eastern Europe and France. Currently, Mr. Clark is on the board of directors of several public biopharmaceutical and biotechnology companies: Takeda Pharmaceutical Company Limited, Guardant Health, Inc., Olema Oncology and Kyverna Therapeutics, Inc. Mr. Clark previously served on the Boards of Forty Seven Inc., Shire Pharmaceuticals, Inc., Kite Pharma, Inc., Agios Pharmaceuticals, Inc. and Avrobio, Inc. He was also on the Board of Biotechnology Industry Association, on the Economic Advisory Council of the 12th District of the Federal Reserve and on the BioFulcrum Board of the Gladstone Institute. Mr. Clark received his Bachelor of Science in Biological Sciences and an Honorary Doctorate of Science from Southampton University in the United Kingdom.
- Irene Chang Britt
-
Irene Chang Britt，自2010年10月，在一家生产/销售高质量食品的公司，Campbell Soup公司担任高级副总裁和首席战略官。她于2005年加入Campbell Soup，从2008年12月的到2010年9月曾担任Campbell Soup北美餐饮部的总统，从2005年12月到2008年11月担任调料部的副总裁和经理。此前，她卡夫食品股份有限公司，Nabisco（全球零食销售商）和Kimberly-Clark（个人护理产品营销者）担任各种行政级别的职位。2005年，她在卡夫食品，Nabisco谷物部担任高级副总裁和总经理，咸点心部的高级副总裁和总经理（2004-2005）；点心部的副总裁（2001-2003）；加拿大饼干和零食的副总裁和商业领袖（2000-2001年）和整合营销策略的副总裁（1999-2000）。
Irene Chang Britt served as President, Pepperidge Farm, a subsidiary of Campbell Soup Company from August 2012 to February 2015 and also held the position of Senior Vice President, Global Baking and Snacking for Campbell from October 2010 to February 2015. Ms. Chang Britt joined Campbell in 2005 and held a series of leadership positions with Campbell including Senior Vice President and Chief Strategy Officer and President, North America Foodservice. Ms. Chang Britt currently serves on the board of directors of Tailored Brands, Inc. and TerraVia Holdings, Inc., and formerly served on the board of Sunoco, Inc. - Irene Chang Britt，自2010年10月，在一家生产/销售高质量食品的公司，Campbell Soup公司担任高级副总裁和首席战略官。她于2005年加入Campbell Soup，从2008年12月的到2010年9月曾担任Campbell Soup北美餐饮部的总统，从2005年12月到2008年11月担任调料部的副总裁和经理。此前，她卡夫食品股份有限公司，Nabisco（全球零食销售商）和Kimberly-Clark（个人护理产品营销者）担任各种行政级别的职位。2005年，她在卡夫食品，Nabisco谷物部担任高级副总裁和总经理，咸点心部的高级副总裁和总经理（2004-2005）；点心部的副总裁（2001-2003）；加拿大饼干和零食的副总裁和商业领袖（2000-2001年）和整合营销策略的副总裁（1999-2000）。
- Irene Chang Britt served as President, Pepperidge Farm, a subsidiary of Campbell Soup Company from August 2012 to February 2015 and also held the position of Senior Vice President, Global Baking and Snacking for Campbell from October 2010 to February 2015. Ms. Chang Britt joined Campbell in 2005 and held a series of leadership positions with Campbell including Senior Vice President and Chief Strategy Officer and President, North America Foodservice. Ms. Chang Britt currently serves on the board of directors of Tailored Brands, Inc. and TerraVia Holdings, Inc., and formerly served on the board of Sunoco, Inc.
- James R. Craigie
-
James R. Craigie，2013年起担任本公司董事。他从2007年起，担任Church & Dwight的董事长、首席执行官，这是一个包装消费品公司；2004年7月至2007年5月，担任其总裁、首席执行官；2004年起，担任其董事。1998年12月至2003年9月，他担任Spalding Sports Worldwide及其继任公司Top-Flite Golf的总裁、首席执行官、董事。1983年至1998年11月，他在Kraft Foods担任过各种高级管理职务。进入私营行业之前，他曾是美国海军的军官，服役时间6年。他目前是媒体与营销公司Meredith Corporation的董事，将于2014年5月7日正式离任；也是休闲餐饮公司Bloomin' Brands和Gettysburg Foundation的董事，后者是致力于重建Gettysburg战场的非营利机构。
James R. Craigie has been a member of the board of directors since 2013. He has been the Chairman of Church & Dwight Co., Inc., a leading developer, manufacturer and marketer of household and personal care consumer packaged goods, since 2007. From June 2007 to December 2015 he was the Chairman and Chief Executive Officer of Church & Dwight, and from July 2004 through May 2007 he was the President and Chief Executive Officer of Church & Dwight. He has served on the board of directors of Church & Dwight since 2004. From December 1998 through September 2003 he was President, Chief Executive Officer and a member of the board of directors of Spalding Sports Worldwide and its successor, Top-Flite Golf Co. During the period from 1983 to November 1998 Mr. Craigie held various senior management positions with Kraft Foods Inc. Prior to entering private industry, he served for six years as an officer in the U.S. Navy/Department of Energy working for Admiral Rickover. He currently serves as a member of the boards of directors of Bloomin’ Brands, Inc., a casual dining company and the Gettysburg Foundation, a non-profit foundation involved with restoring the Gettysburg battlefields. Mr. Craigie holds an undergraduate degree from the University of Rochester and an M.B.A. from Harvard University. - James R. Craigie，2013年起担任本公司董事。他从2007年起，担任Church & Dwight的董事长、首席执行官，这是一个包装消费品公司；2004年7月至2007年5月，担任其总裁、首席执行官；2004年起，担任其董事。1998年12月至2003年9月，他担任Spalding Sports Worldwide及其继任公司Top-Flite Golf的总裁、首席执行官、董事。1983年至1998年11月，他在Kraft Foods担任过各种高级管理职务。进入私营行业之前，他曾是美国海军的军官，服役时间6年。他目前是媒体与营销公司Meredith Corporation的董事，将于2014年5月7日正式离任；也是休闲餐饮公司Bloomin' Brands和Gettysburg Foundation的董事，后者是致力于重建Gettysburg战场的非营利机构。
- James R. Craigie has been a member of the board of directors since 2013. He has been the Chairman of Church & Dwight Co., Inc., a leading developer, manufacturer and marketer of household and personal care consumer packaged goods, since 2007. From June 2007 to December 2015 he was the Chairman and Chief Executive Officer of Church & Dwight, and from July 2004 through May 2007 he was the President and Chief Executive Officer of Church & Dwight. He has served on the board of directors of Church & Dwight since 2004. From December 1998 through September 2003 he was President, Chief Executive Officer and a member of the board of directors of Spalding Sports Worldwide and its successor, Top-Flite Golf Co. During the period from 1983 to November 1998 Mr. Craigie held various senior management positions with Kraft Foods Inc. Prior to entering private industry, he served for six years as an officer in the U.S. Navy/Department of Energy working for Admiral Rickover. He currently serves as a member of the boards of directors of Bloomin’ Brands, Inc., a casual dining company and the Gettysburg Foundation, a non-profit foundation involved with restoring the Gettysburg battlefields. Mr. Craigie holds an undergraduate degree from the University of Rochester and an M.B.A. from Harvard University.
高管简历
中英对照 | 中文 | 英文- Apurva S. Mody
ApurvaS.Mody自2016年以来一直担任我们的首席执行官兼董事会成员。在加入我们之前，他曾于2010年至2015年担任Mars，Inc.的Mars Food America总裁。从2008年到2010年，他担任消费品创新公司The Brand Accelerator的首席执行官，从2002年到2008年，他曾担任Del Monte Foods公司（食品公司）的多种职务，最近担任消费品部门的高级副总裁兼董事总经理。从1995年到2000年，Mody先生在宝洁公司（Proctor and Gamble Company）担任多个职位，该公司是一家包装消费品公司，最近担任全球新产品开发的高级品牌经理。Mody先生拥有密歇根大学（University of Michigan）的本科学位和密歇根大学（University of Michigan）的工商管理硕士学位。
Apurva S. Mody has been our Chief Executive Officer and member of our board of directors since 2016. Prior to joining us, he was President, Mars Food America, at Mars, Inc. from 2010 to 2015. From 2008 to 2010 he was Chief Executive Officer of The Brand Accelerator, a consumer goods innovation company, and from 2002 to 2008 he held various positions within Del Monte Foods, a food company, most recently as Senior Vice President and Managing Director, Consumer Products Division. From 1995 to 2000 Mr. Mody held various positions with The Proctor and Gamble Company, a consumer packaged goods company, most recently Senior Brand Manager, Global New Product Development. Mr. Mody holds an undergraduate degree from the University of Michigan and an M.B.A. with Distinction from the University of Michigan.- ApurvaS.Mody自2016年以来一直担任我们的首席执行官兼董事会成员。在加入我们之前，他曾于2010年至2015年担任Mars，Inc.的Mars Food America总裁。从2008年到2010年，他担任消费品创新公司The Brand Accelerator的首席执行官，从2002年到2008年，他曾担任Del Monte Foods公司（食品公司）的多种职务，最近担任消费品部门的高级副总裁兼董事总经理。从1995年到2000年，Mody先生在宝洁公司（Proctor and Gamble Company）担任多个职位，该公司是一家包装消费品公司，最近担任全球新产品开发的高级品牌经理。Mody先生拥有密歇根大学（University of Michigan）的本科学位和密歇根大学（University of Michigan）的工商管理硕士学位。
- Apurva S. Mody has been our Chief Executive Officer and member of our board of directors since 2016. Prior to joining us, he was President, Mars Food America, at Mars, Inc. from 2010 to 2015. From 2008 to 2010 he was Chief Executive Officer of The Brand Accelerator, a consumer goods innovation company, and from 2002 to 2008 he held various positions within Del Monte Foods, a food company, most recently as Senior Vice President and Managing Director, Consumer Products Division. From 1995 to 2000 Mr. Mody held various positions with The Proctor and Gamble Company, a consumer packaged goods company, most recently Senior Brand Manager, Global New Product Development. Mr. Mody holds an undergraduate degree from the University of Michigan and an M.B.A. with Distinction from the University of Michigan.
- Tyler W. Painter
Tyler W. Painter，2007年起，担任本公司的首席财务官。加入本公司之前，2007年5月至2007年10月，他担任PMC-Sierra PMCS的临时财务总监，这是宽带通信与互联网基础架构半导体解决方案供应商。2001-2007，他在软件公司Wind River Systems担任财务与投资者关系副总裁、企业财务总管。加入Wind River Systems之前，他在CarsDirect和Gap担任过各种财务职位；前者是在线汽车销售公司，后者是服装零售公司。他在California Polytechnic State University, San Luis Obispo获得工商管理学士学位。
Tyler W. Painter has served as our Chief Financial Officer since 2007 and our Chief Operating Officer since 2014. Prior to joining us, Mr. Painter served as interim Corporate Controller for PMC-Sierra PMCS, a provider of broadband communications and internet infrastructure semiconductor solutions, from May 2007 through October 2007. From 2001 to 2007 Mr. Painter served as Vice President of Finance and Investor Relations and Corporate Treasurer for Wind River Systems, Inc., a software company. Prior to joining Wind River Systems, Inc., Mr. Painter held a variety of positions in finance at CarsDirect, Inc., an online automobile sales company, and at Gap, Inc., a retail clothing company. Mr. Painter obtained a B.S. in Business Administration/Finance from California Polytechnic State University, San Luis Obispo.- Tyler W. Painter，2007年起，担任本公司的首席财务官。加入本公司之前，2007年5月至2007年10月，他担任PMC-Sierra PMCS的临时财务总监，这是宽带通信与互联网基础架构半导体解决方案供应商。2001-2007，他在软件公司Wind River Systems担任财务与投资者关系副总裁、企业财务总管。加入Wind River Systems之前，他在CarsDirect和Gap担任过各种财务职位；前者是在线汽车销售公司，后者是服装零售公司。他在California Polytechnic State University, San Luis Obispo获得工商管理学士学位。
- Tyler W. Painter has served as our Chief Financial Officer since 2007 and our Chief Operating Officer since 2014. Prior to joining us, Mr. Painter served as interim Corporate Controller for PMC-Sierra PMCS, a provider of broadband communications and internet infrastructure semiconductor solutions, from May 2007 through October 2007. From 2001 to 2007 Mr. Painter served as Vice President of Finance and Investor Relations and Corporate Treasurer for Wind River Systems, Inc., a software company. Prior to joining Wind River Systems, Inc., Mr. Painter held a variety of positions in finance at CarsDirect, Inc., an online automobile sales company, and at Gap, Inc., a retail clothing company. Mr. Painter obtained a B.S. in Business Administration/Finance from California Polytechnic State University, San Luis Obispo.
- Peter J. Licari
Peter J. Licari，2012年起，担任本公司的首席技术官。2010-2012，他担任本公司的研发执行副总裁；2008-2010，担任研发高级副总裁。1998-2008，他在生物制药公司Kosan Biosciences担任过多个职务，最后的是制造与运营高级副总裁，负责其临床化合物的工艺开发和生产。1993-1996，他担任 Massachusetts Biologic Laboratories的疫苗生产和开发总监，这是学术机构University of Massachusetts的分部。加入Massachusetts Biologic Laboratories之前，他在生物制药公司BASF Bioresearch Corporation和制药公司Merck & Co工作过，担任过各种研究性的职务。他在California Institute of Technology获得化学工程博士学位，在Pepperdine University获工商管理硕士学位。
Peter J. Licari has served as our Chief Technology Officer since 2012. From 2010 to 2012 he served as our Executive Vice President, Research and Development. He served as our Senior Vice President, Research and Development from 2008 until 2010. From 1998 to 2008 Dr. Licari held various positions at Kosan Biosciences, Inc., a biopharmaceutical company. In his last position at Kosan Biosciences, Inc. he served as Senior Vice President, Manufacturing and Operations responsible for the process development and manufacturing of Kosan’s clinical compounds. From 1993 to 1996 Dr. Licari served as the Director of Vaccine Manufacturing and Development at Massachusetts Biologic Laboratories, a part of the University of Massachusetts, an academic institution. Prior to joining Massachusetts Biologic Laboratories, Dr. Licari held a variety of research positions at BASF Bioresearch Corporation, a biopharmaceutical company, and Merck & Co., Inc., a pharmaceutical company. Dr. Licari obtained his Ph.D. in Chemical Engineering from the California Institute of Technology and obtained an M.B.A. from Pepperdine University.- Peter J. Licari，2012年起，担任本公司的首席技术官。2010-2012，他担任本公司的研发执行副总裁；2008-2010，担任研发高级副总裁。1998-2008，他在生物制药公司Kosan Biosciences担任过多个职务，最后的是制造与运营高级副总裁，负责其临床化合物的工艺开发和生产。1993-1996，他担任 Massachusetts Biologic Laboratories的疫苗生产和开发总监，这是学术机构University of Massachusetts的分部。加入Massachusetts Biologic Laboratories之前，他在生物制药公司BASF Bioresearch Corporation和制药公司Merck & Co工作过，担任过各种研究性的职务。他在California Institute of Technology获得化学工程博士学位，在Pepperdine University获工商管理硕士学位。
- Peter J. Licari has served as our Chief Technology Officer since 2012. From 2010 to 2012 he served as our Executive Vice President, Research and Development. He served as our Senior Vice President, Research and Development from 2008 until 2010. From 1998 to 2008 Dr. Licari held various positions at Kosan Biosciences, Inc., a biopharmaceutical company. In his last position at Kosan Biosciences, Inc. he served as Senior Vice President, Manufacturing and Operations responsible for the process development and manufacturing of Kosan’s clinical compounds. From 1993 to 1996 Dr. Licari served as the Director of Vaccine Manufacturing and Development at Massachusetts Biologic Laboratories, a part of the University of Massachusetts, an academic institution. Prior to joining Massachusetts Biologic Laboratories, Dr. Licari held a variety of research positions at BASF Bioresearch Corporation, a biopharmaceutical company, and Merck & Co., Inc., a pharmaceutical company. Dr. Licari obtained his Ph.D. in Chemical Engineering from the California Institute of Technology and obtained an M.B.A. from Pepperdine University.
- Paul T. Quinlan
Paul T. Quinlan，2010年起，担任本公司法律总顾问、企业秘书。2005-2010，他在生物制药公司Metabolex担任法律总顾问，负责法律事务。2000-2005，他在生物制药公司Maxygen的法律部门担任过各种职务，最后的是公司证券首席法律顾问。加入Maxygen之前，他是律师事务所Cooley LLP和Cravath, Swaine & Moore LLP的律师。他在Columbia University Law School获得法律学位，在University of Toronto获得医学生物物理硕士学位。
Paul T. Quinlan has served as our General Counsel and Corporate Secretary since 2010 and our Chief Legal Officer since 2016. From 2005 to 2010 Mr. Quinlan was General Counsel at Metabolex, Inc., a biopharmaceutical company. In this position, he was responsible for overseeing the legal affairs of Metabolex, Inc. From 2000 to 2005 Mr. Quinlan held various positions in the legal department at Maxygen, Inc., a biopharmaceutical company, most recently that of Chief Corporate Securities Counsel. Prior to joining Maxygen, Inc., Mr. Quinlan was an associate at Cooley LLP, a law firm, and Cravath, Swaine & Moore LLP, a law firm. Mr. Quinlan obtained a law degree from Columbia University Law School and a M.Sc. in Medical Biophysics from the University of Toronto.- Paul T. Quinlan，2010年起，担任本公司法律总顾问、企业秘书。2005-2010，他在生物制药公司Metabolex担任法律总顾问，负责法律事务。2000-2005，他在生物制药公司Maxygen的法律部门担任过各种职务，最后的是公司证券首席法律顾问。加入Maxygen之前，他是律师事务所Cooley LLP和Cravath, Swaine & Moore LLP的律师。他在Columbia University Law School获得法律学位，在University of Toronto获得医学生物物理硕士学位。
- Paul T. Quinlan has served as our General Counsel and Corporate Secretary since 2010 and our Chief Legal Officer since 2016. From 2005 to 2010 Mr. Quinlan was General Counsel at Metabolex, Inc., a biopharmaceutical company. In this position, he was responsible for overseeing the legal affairs of Metabolex, Inc. From 2000 to 2005 Mr. Quinlan held various positions in the legal department at Maxygen, Inc., a biopharmaceutical company, most recently that of Chief Corporate Securities Counsel. Prior to joining Maxygen, Inc., Mr. Quinlan was an associate at Cooley LLP, a law firm, and Cravath, Swaine & Moore LLP, a law firm. Mr. Quinlan obtained a law degree from Columbia University Law School and a M.Sc. in Medical Biophysics from the University of Toronto.